124 related articles for article (PubMed ID: 8745316)
1. Interferon-alpha 2a for chronic hepatitis B with e antigen or antibody:comparable antiviral effects on wild-type virus and precore mutant.
Aikawa T; Kanai K; Kako M; Kawasaki T; Hino K; Iwabuchi S; Tsubouchi H; Takehira Y; Tsuda F; Okamoto H
J Viral Hepat; 1995; 2(5):243-50. PubMed ID: 8745316
[TBL] [Abstract][Full Text] [Related]
2. Relationship between the serum alanine aminotransferase level at the end of interferon treatment and histologic changes in wild-type and precore mutant hepatitis B virus infections.
Bayraktar Y; Koseoglu T; Temizer A; Kayhan B; Van Thiel DH; Uzunalimoglu B
J Viral Hepat; 1996 May; 3(3):137-42. PubMed ID: 8871872
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis B virus precore mutants in HBeAg carriers with chronic hepatitis treated with interferon.
Lampertico P; Manzin A; Rumi MG; Paolucci S; Del Ninno E; Clementi M; Colombo M
J Viral Hepat; 1995; 2(5):251-6. PubMed ID: 8745317
[TBL] [Abstract][Full Text] [Related]
4. Analysis of hepatitis B virus precore variants in hepatitis B e antibody-positive patients treated with prednisone plus interferon.
Lopez-Alcorocho JM; Cabrerizo M; Bartolome J; Cotonat T; Carreño V
J Viral Hepat; 1995; 2(6):279-84. PubMed ID: 8732173
[TBL] [Abstract][Full Text] [Related]
5. Genetic heterogeneity in the precore region of hepatitis B virus in hepatitis B e antigen-negative chronic hepatitis B patients: spontaneous seroconversion and interferon-induced seroconversion.
Karasawa T; Aizawa Y; Zeniya M; Kuramoto A; Shirasawa T; Toda G
J Med Virol; 1995 Apr; 45(4):373-80. PubMed ID: 7666040
[TBL] [Abstract][Full Text] [Related]
6. Core promoter mutations of hepatitis B virus for the response to interferon in e antigen-positive chronic hepatitis B.
Kanai K; Kako M; Aikawa T; Hino K; Tsubouchi H; Takehira Y; Iwabuchi S; Kawasaki T; Tsuda F; Okamoto H; Miyakawa Y; Mayumi M
Am J Gastroenterol; 1996 Oct; 91(10):2150-6. PubMed ID: 8855739
[TBL] [Abstract][Full Text] [Related]
7. Low-dose recombinant interferon therapy in anti-HBe-positive chronic hepatitis B in Asian Indians.
Guptan RC; Thakur V; Malhotra V; Sarin SK
J Gastroenterol Hepatol; 1998 Jul; 13(7):675-9. PubMed ID: 9715416
[TBL] [Abstract][Full Text] [Related]
8. Effects of interferon alpha therapy on the catalytic domains of the polymerase gene and basal core promoter, precore and core regions of hepatitis B virus.
Chen RY; Bowden S; Desmond PV; Dean J; Locarnini SA
J Gastroenterol Hepatol; 2003 Jun; 18(6):630-7. PubMed ID: 12753143
[TBL] [Abstract][Full Text] [Related]
9. Nucleotide sequence analysis of precore and proximal core regions in patients with chronic hepatitis B treated with interferon.
Laskus T; Rakela J; Persing DH
Dig Dis Sci; 1995 Jan; 40(1):1-7. PubMed ID: 7821093
[TBL] [Abstract][Full Text] [Related]
10. Precore mutant hepatitis B virus and outcome of chronic infection and hepatitis in hepatitis B e antigen-positive children.
Barbera C; Calvo P; Coscia A; Perugini L; Dastoli G; Randone A; Bonino F; Brunetto MR
Pediatr Res; 1994 Sep; 36(3):347-50. PubMed ID: 7528908
[TBL] [Abstract][Full Text] [Related]
11. Presence of precore and core promoter mutants limits the probability of response to peginterferon in hepatitis B e antigen-positive chronic hepatitis B.
Sonneveld MJ; Rijckborst V; Zeuzem S; Heathcote EJ; Simon K; Senturk H; Pas SD; Hansen BE; Janssen HL
Hepatology; 2012 Jul; 56(1):67-75. PubMed ID: 22307831
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B Virus Precore Protein p22 Inhibits Alpha Interferon Signaling by Blocking STAT Nuclear Translocation.
Mitra B; Wang J; Kim ES; Mao R; Dong M; Liu Y; Zhang J; Guo H
J Virol; 2019 Jul; 93(13):. PubMed ID: 31019054
[TBL] [Abstract][Full Text] [Related]
13. Low pretreatment serum HBsAg level and viral mutations as predictors of response to PEG-interferon alpha-2b therapy in chronic hepatitis B.
Tangkijvanich P; Komolmit P; Mahachai V; Sa-nguanmoo P; Theamboonlers A; Poovorawan Y
J Clin Virol; 2009 Oct; 46(2):117-23. PubMed ID: 19651540
[TBL] [Abstract][Full Text] [Related]
14. [Effects of interferon treatment on mutation of hepatitis B virus precore genome].
Hu D; Li X; Xiong S
Zhonghua Nei Ke Za Zhi; 1995 Apr; 34(4):229-31. PubMed ID: 7587599
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis B virus precore mutations and HBeAg negative reactivation of chronic hepatitis B after interferon therapy.
Talbodec N; Loriot MA; Gigou M; Guigonis V; Boyer N; Bezeaud A; Erlinger S; Benhamou JP; Marcellin P
Liver; 1995 Apr; 15(2):93-8. PubMed ID: 7540713
[TBL] [Abstract][Full Text] [Related]
16. Absence of hepatitis B virus precore mutants in patients with chronic hepatitis B responding to interferon-alpha.
Xu J; Brown D; Harrison T; Lin Y; Dusheiko G
Hepatology; 1992 Jun; 15(6):1002-6. PubMed ID: 1592338
[TBL] [Abstract][Full Text] [Related]
17. Interferon-alpha 2b improves short-term survival in patients transplanted for chronic liver failure caused by hepatitis B.
Hassanein T; Colantoni A; De Maria N; Van Thiel DH
J Viral Hepat; 1996 Nov; 3(6):333-40. PubMed ID: 8947886
[TBL] [Abstract][Full Text] [Related]
18. Genetic heterogeneity of the precore and the core promoter region of genotype C hepatitis B virus during lamivudine therapy.
Kuwahara R; Kumashiro R; Murashima S; Ogata K; Tanaka K; Hisamochi A; Hino T; Ide T; Tanaka E; Koga Y; Sata M
J Med Virol; 2004 Jan; 72(1):26-34. PubMed ID: 14635007
[TBL] [Abstract][Full Text] [Related]
19. Low frequency of precore hepatitis B virus mutants in anti-hepatitis B e-positive reactivation after loss of hepatitis B e antigen in patients with chronic hepatitis B.
Loriot MA; Marcellin P; Talbodec N; Guigonis V; Gigou M; Boyer N; Bezeaud A; Erlinger S; Benhamou JP
Hepatology; 1995 Mar; 21(3):627-31. PubMed ID: 7875659
[TBL] [Abstract][Full Text] [Related]
20. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B.
Lin CL; Liao LY; Liu CJ; Chen PJ; Lai MY; Kao JH; Chen DS
J Gastroenterol; 2002; 37(4):283-7. PubMed ID: 11993512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
